BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 23489505)

  • 1. 2D map of proteins from human renal stone matrix and evaluation of their effect on oxalate induced renal tubular epithelial cell injury.
    Aggarwal KP; Tandon S; Singh SK; Tandon C
    Int Braz J Urol; 2013; 39(1):128-36. PubMed ID: 23489505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel antilithiatic cationic proteins from human calcium oxalate renal stone matrix identified by MALDI-TOF-MS endowed with cytoprotective potential: an insight into the molecular mechanism of urolithiasis.
    Aggarwal KP; Tandon S; Naik PK; Singh SK; Tandon C
    Clin Chim Acta; 2013 Jan; 415():181-90. PubMed ID: 23123287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometric identification of human phosphate cytidylyltransferase 1 as a novel calcium oxalate crystal growth inhibitor purified from human renal stone matrix.
    Priyadarshini ; Singh SK; Tandon C
    Clin Chim Acta; 2009 Oct; 408(1-2):34-8. PubMed ID: 19595683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peeping into human renal calcium oxalate stone matrix: characterization of novel proteins involved in the intricate mechanism of urolithiasis.
    Aggarwal KP; Tandon S; Naik PK; Singh SK; Tandon C
    PLoS One; 2013; 8(7):e69916. PubMed ID: 23894559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of myeloperoxidase, alpha-defensin and calgranulin in calcium oxalate renal stones.
    Mushtaq S; Siddiqui AA; Naqvi ZA; Rattani A; Talati J; Palmberg C; Shafqat J
    Clin Chim Acta; 2007 Sep; 384(1-2):41-7. PubMed ID: 17610860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi.
    McKee MD; Nanci A; Khan SR
    J Bone Miner Res; 1995 Dec; 10(12):1913-29. PubMed ID: 8619372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteome of human calcium kidney stones.
    Canales BK; Anderson L; Higgins L; Ensrud-Bowlin K; Roberts KP; Wu B; Kim IW; Monga M
    Urology; 2010 Oct; 76(4):1017.e13-20. PubMed ID: 20709378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An oxalate-binding protein with crystal growth promoter activity from human kidney stone matrix.
    Govindaraj A; Selvam R
    BJU Int; 2002 Aug; 90(3):336-44. PubMed ID: 12133075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular mechanism of renal stone formation].
    Hamamoto S; Taguchi K; Fujii Y
    Clin Calcium; 2011 Oct; 21(10):1481-7. PubMed ID: 21960233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulatory effects of fibronectin on calcium oxalate crystallization, growth, aggregation, adhesion on renal tubular cells, and invasion through extracellular matrix.
    Khamchun S; Sueksakit K; Chaiyarit S; Thongboonkerd V
    J Biol Inorg Chem; 2019 Mar; 24(2):235-246. PubMed ID: 30701361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large-scale identification of calcium oxalate monohydrate crystal-binding proteins on apical membrane of distal renal tubular epithelial cells.
    Fong-Ngern K; Peerapen P; Sinchaikul S; Chen ST; Thongboonkerd V
    J Proteome Res; 2011 Oct; 10(10):4463-77. PubMed ID: 21859077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones.
    Evan AP; Coe FL; Gillen D; Lingeman JE; Bledsoe S; Worcester EM
    Anat Rec (Hoboken); 2008 Mar; 291(3):325-34. PubMed ID: 18286613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal surface adhesion explains the pathological activity of calcium oxalate hydrates in kidney stone formation.
    Sheng X; Ward MD; Wesson JA
    J Am Soc Nephrol; 2005 Jul; 16(7):1904-8. PubMed ID: 15930089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of biomolecules from human renal matrix of calcium oxalate monohydrate (CaOx) stones on in vitro calcium phosphate crystallization.
    Pathak P; Singh SK; Tandon C
    Int Braz J Urol; 2010; 36(5):621-8. PubMed ID: 21044380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
    Khan SR; Thamilselvan S
    Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic Insights into the Antilithiatic Proteins from Terminalia arjuna: A Proteomic Approach in Urolithiasis.
    Mittal A; Tandon S; Singla SK; Tandon C
    PLoS One; 2016; 11(9):e0162600. PubMed ID: 27649531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oxalate on the growth of renal tubular epithelial cells.
    Kim HH; Kwak C; Jeong BC; Kim SW
    J Endourol; 2002 May; 16(4):261-4. PubMed ID: 12042112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney stone matrix proteins ameliorate calcium oxalate monohydrate induced apoptotic injury to renal epithelial cells.
    Narula S; Tandon S; Singh SK; Tandon C
    Life Sci; 2016 Nov; 164():23-30. PubMed ID: 27593572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of a protein inhibitor isolated from human renal stone matrix in urolithiasis.
    Aggarwal S; Tandon C; Forouzandeh M; Singla SK; Kiran R; Jethi RK
    Indian J Biochem Biophys; 2005 Apr; 42(2):113-7. PubMed ID: 23923571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human kidney stone matrix proteins alleviate hyperoxaluria induced renal stress by targeting cell-crystal interactions.
    Narula S; Tandon S; Kumar D; Varshney S; Adlakha K; Sengupta S; Singh SK; Tandon C
    Life Sci; 2020 Dec; 262():118498. PubMed ID: 32991878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.